
A consistent association with zzso zzso zzso zzso acquired zzso syndrome zzso primary central nervous system zzso zzso from that which occurs in the general zzso Recent descriptions of long-term zzso in patients with zzso zzso zzso who received zzso therapy suggest some zzso effect is zzso zzso 

We enrolled 4 patients with AIDS-related zzso into a novel zzso and zzso zzso An additional patient was treated in a similar fashion off zzso Treatment consisted of zzso administered zzso zzso g twice daily), zzso (5 zzso twice daily), and zzso zzso U twice zzso After 2 weeks of therapy, patients were switched to oral zzso (1 g 3 times daily), zzso highly active, zzso therapy, and subcutaneous zzso zzso U 3 times zzso A final patient was treated with intravenous zzso and zzso All 6 patients had zzso AIDS as reflected by a zzso zzso cell count of zzso zzso and a zzso human zzso virus zzso viral zzso load zzso copies, zzso range, zzso One of 4 zzso patients remains in complete zzso with zzso 4 years' zzso 

Three patients died from complications of progressive zzso Two patients treated off protocol exhibited favorable responses and remain in complete zzso at 28 months and 52 months, zzso Grade 3/4 zzso was zzso noted, but there were no clinically significant zzso or infectious zzso 

We conclude that for patients with AIDS and zzso treatments with dual efficacy against zzso and zzso merit further zzso Our experience provides a platform for future zzso 

